One hundred and five hepatitis B surface antigen (HBsAg) positive patients presenting with chronic persistent hepatitis (n=46) or chronic active hepatitis without cirrhosis (n= 59) were followed longitudinally for one to 16 years (mean 5.5 years) and underwent follow up biopsy. During a mean histological follow up of 3*7 years, active cirrhosis developed in 21 (20%) patients one to 13 years after entry to the study with a calculated annual incidence of 5.9%/o. The probability of evolution to cirrhosis was significantly higher in patients with chronic active hepatitis and bridging hepatic necrosis than in those with moderate chronic active hepatitis or chronic persistent hepatitis (p<0*0001). Cox multiple regression analysis showed that the following three variables independently implied poor prognosis: older age, presence of bridging hepatic necrosis, and persistence of hepatitis B virus DNA in serum (p<0-0001). These findings indicate that patients with severe chronic active hepatitis and persistent hepatitis B virus replication are at very high risk of rapid progression to cirrhosis.
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The cla do Multivariate analysis using the stepwise Cox regression analysis indicated that older age, presence of severe chronic active hepatitis with bridging hepatic necrosis, and continuing HBV replication were independent predictors of progression to cirrhosis (Table IV) .
The 21 patients who developed cirrhosis were followed for an additional one to nine years after histological deterioration. All were examined endoscopically and three were noted to have developed oesophageal varices. None of our patients died.
Two patients underwent seroconversion from HBeAg to anti-HBe with HBV-DNA clearance and a return of alanine aminotransferase to normal one and four years after development of cirrhosis, while another anti-HBe positive patient cleared HBV-DNA from serum with biochemical remission one year after being diagnosed as cirrhotic.
No HDV events were seen during follow up of the 105 patients with chronic HBV infection.
Discussion
In this investigation we have analysed the natural history and prognostic factors in chronic HBV infection and were able to trace the course of the disease with follow up liver biopsies in all patients. Twenty one (20%) of the 105 untreated patients with HBsAg positive chronic hepatitis and without HDV infection showed progression to cirrhosis during a mean histological follow up period of 3-7 years. The cumulative probability of cirrhosis in our patients at the end of the fifth year was 20%, and these data are very close to the Patients who developed cirrhosis were older and the meaning of this finding is unclear. It is suggested that host factors and in particular an impaired function of the immune system occurring in older people may lead to persistent HBV replication and continuous liver damage.
Multivariate analysis showed that the presence of bridging hepatic necrosis and continuing viral replication were the most important risk factors studied. Indeed extensive necrosis of hepatocytes either bridging the lobule or multilobular necrosis seems to identify patients who are particularly liable to develop cirrhosis. Histological severity also influenced a more rapid deterioration. Our data obtained in a longitudinal study indicate that chronic active hepatitis with bridging necrosis is a serious disease that frequently ends in cirrhosis, thus confirming previous investigations. 12 On the contrary, an initial histology of moderate chronic active or chronic persistent hepatitis did not seem to make much difference to the outcome, since the possibility of developing cirrhosis in patients with chronic active disease without bridging necrosis was not greater than that in patients with chronic persistent hepatitis.
Ongoing HBV replication and expression of viral antigens at the liver cell surface are certainly important determinants for the pathogenesis of HBV-associated liver disease.20"2 The continued replication of the virus may be responsible for the perpetuation of the immune mediated cytotoxic reaction and liver cell injury, thus leading to the evolution of cirrhosis. In fact most of our patients were persistently HBV-DNA positive in serum, irrespective of the HBeAg/anti-HBe system when cirrhosis was first diagnosed. No patient died and few complications were observed during one to nine years of follow up after the development of cirrhosis.
Our results agree with previous data which indicate that patients with compensated cirrhosis remain in the same condition for many years after diagnosis.26
In conclusion, virological markers at diagnosis are somewhat disappointing in terms of prognostic assessment and only the evaluation of virological changes during follow up seems useful in defining the outcome of liver disease. Of the clinical data at presentation, the most important seems to be the presence of bridging necrosis, while no differences were observed in terms of prognosis between moderate chronic active or chronic persistent hepatitis. Our results suggest that patients with severe chronic active hepatitis and lengthy persistence of HBV replication are at very high risk of rapid progression to cirrhosis.
